O
BSTC

OppenheimerFunds’s BioSpecifics Technologies Corp. BSTC Stock Holding History

OppenheimerFunds’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$233K Buy
+3,729
New +$247K ﹤0.01% 1656

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
TAM
THB Asset Management Norwalk, Connecticut $440M AUM 59.59% 1-Year Est. Return

OppenheimerFunds's BSTC Position: Q1 2019 in Review

OppenheimerFunds opened a new position in BioSpecifics Technologies Corp. (BSTC) in Q1 2019: 3,729 shares worth $233K. The stake represents ﹤0.01% of the portfolio and ranks #1656 among its holdings.

117 funds tracked by Wall St. Rank hold BSTC as of Q1 2019.

  • OppenheimerFunds held 3,729 shares of BioSpecifics Technologies Corp. worth $233K as of Q1 2019.
  • BioSpecifics Technologies Corp. was a new OppenheimerFunds position in Q1 2019.
  • BioSpecifics Technologies Corp. made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #1656 holding.
  • 117 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.